MW Medical Receives FDA Clearance for New Microwave Applicator

Apr 03, 2001, 01:00 ET from MW Medical

    SCOTTSDALE, Ariz., April 3 /PRNewswire/ -- MW Medical
 (OTC Bulletin Board:   MWMD) received FDA clearance for its new, large aperture
 hair removal applicator.  This accessory for the MW 2000 hair removal system
 provides a significantly larger treatment footprint to improve operator
 efficiency and increase treatment efficacy.
     The clinical trial was performed in December, 2000 by Dr. David Duffy of
 Torrance, CA., under an IRB approved protocol with monitoring by MW Medical
 clinical personnel.  After following patients for the prescribed period of the
 trial, the data was submitted to the FDA to support the 510(k) filing to begin
 marketing this new accessory.  "We are indebted to Dr. Duffy and his staff for
 their interest in the project and quality of this study.  Their dedication and
 diligence throughout the process was outstanding," states Tyler Brown, MW
 Medical COO.
     Due to the nature of the accessory and the company's earlier approval,
 MW Medical requested and was granted a special 510(k) clearance.  The trial
 was completed with one hundred percent compliance and zero adverse events.
 "This was truly an outstanding effort on all fronts -- the development team,
 Dr. Duffy and the clinical staff and our regulatory advisors -- all worked
 closely to make this project run flawlessly," stated Jan Wallace, MW Medical
 CEO.  Regulatory Specialists of Irvine, CA. served as consultants to the
 company on the project and continue to support on-going clinical/regulatory
 development.
     The new applicator's design also incorporates an improved energy
 distribution profile, increased efficiency and a new handle design.  These
 features will provide more effective and efficient energy delivery to the hair
 follicles and a more comfortable design.  This improves target heating while
 enhancing tissue cooling and reducing potential tissue damage at higher energy
 settings.
     MW is particularly pleased with achieving this regulatory clearance, as it
 demonstrates the company's continuing objective to advance the use and safety
 of microwave technology in the medical field.
 
     Statement Under the Private Securities litigation Reform Act
     With the exception of the historical information contained in this
 release, the matters described herein contains forward-looking statements that
 involve risk and uncertainties that may individually or mutually impact the
 matters herein described, including but not limited to product acceptance,
 economic, competitive, governmental, results of litigation, technological
 and/or other factors, which are outside the control of the Company.
 
 

SOURCE MW Medical
    SCOTTSDALE, Ariz., April 3 /PRNewswire/ -- MW Medical
 (OTC Bulletin Board:   MWMD) received FDA clearance for its new, large aperture
 hair removal applicator.  This accessory for the MW 2000 hair removal system
 provides a significantly larger treatment footprint to improve operator
 efficiency and increase treatment efficacy.
     The clinical trial was performed in December, 2000 by Dr. David Duffy of
 Torrance, CA., under an IRB approved protocol with monitoring by MW Medical
 clinical personnel.  After following patients for the prescribed period of the
 trial, the data was submitted to the FDA to support the 510(k) filing to begin
 marketing this new accessory.  "We are indebted to Dr. Duffy and his staff for
 their interest in the project and quality of this study.  Their dedication and
 diligence throughout the process was outstanding," states Tyler Brown, MW
 Medical COO.
     Due to the nature of the accessory and the company's earlier approval,
 MW Medical requested and was granted a special 510(k) clearance.  The trial
 was completed with one hundred percent compliance and zero adverse events.
 "This was truly an outstanding effort on all fronts -- the development team,
 Dr. Duffy and the clinical staff and our regulatory advisors -- all worked
 closely to make this project run flawlessly," stated Jan Wallace, MW Medical
 CEO.  Regulatory Specialists of Irvine, CA. served as consultants to the
 company on the project and continue to support on-going clinical/regulatory
 development.
     The new applicator's design also incorporates an improved energy
 distribution profile, increased efficiency and a new handle design.  These
 features will provide more effective and efficient energy delivery to the hair
 follicles and a more comfortable design.  This improves target heating while
 enhancing tissue cooling and reducing potential tissue damage at higher energy
 settings.
     MW is particularly pleased with achieving this regulatory clearance, as it
 demonstrates the company's continuing objective to advance the use and safety
 of microwave technology in the medical field.
 
     Statement Under the Private Securities litigation Reform Act
     With the exception of the historical information contained in this
 release, the matters described herein contains forward-looking statements that
 involve risk and uncertainties that may individually or mutually impact the
 matters herein described, including but not limited to product acceptance,
 economic, competitive, governmental, results of litigation, technological
 and/or other factors, which are outside the control of the Company.
 
 SOURCE  MW Medical